SELLAS Life Sciences Group, Inc.: cash_and_restricted_cash
| Value | {"amount": 21455000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2021-12-31) |
| Status | current |
| Entity | SELLAS Life Sciences Group, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:26:28.412177+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/36523bd5-8e9f-4aec-aaa7-d198ec2fb6c3
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001390478-22-000006 · Open the official SEC filing →Retrieved: 2026-08-19T13:26:28.412177+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001390478/cash-and-restricted-cash/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/36523bd5-8e9f-4aec-aaa7-d198ec2fb6c3
History
- no predecessors — first report